Meals and snacks labeled “GLP-1 Friendly” are becoming more common in U.S. supermarkets during 2024 and 2025 as the use of prescription weight-loss drugs increases. Medicines such as Wegovy and Zepbound copy the GLP-1 hormone, which lowers appetite and affects digestion, causing many users to eat much smaller portions. A study by the Kaiser Family Foundation found that about 12 percent of U.S. adults were using GLP-1 drugs by late 2024 for weight loss or diabetes treatment. Food companies have reacted to this change by promoting meals designed for smaller portions and higher nutrition. However, the label “GLP-1 Friendly” is not regulated by the U.S. Food and Drug Administration, meaning it does not confirm medical approval or specific health standards.

Nutrition experts say daily food choices remain more important than product labels. Because GLP-1 drugs reduce hunger, experts recommend meals that provide enough protein, fiber, and fluids to reduce common side effects. Dietitians from major medical centers advise eating about 20 to 30 grams of protein per meal and getting enough fiber to support digestion. Some packaged foods meet these needs, but consumers are advised to check labels carefully for high levels of fat, sugar, or sodium. New products from companies such as Nestlé and Conagra show how the food industry is adjusting. Experts say easier meal planning may be a benefit, but long-term health depends on balanced diets and professional guidance.